PAREXEL Academy, a provider of education and professional training for the biopharmaceutical industry in the field of clinical research, which is operated by PAREXEL International, has entered into an agreement with the National University of Singapore (NUS), through its National University of Singapore Academy of GxP Excellence (NUSAGE), to offer an academic program in Singapore to help meet the increasing demand for talent in the field of clinical research in the Asia region. This demand is being driven by the growing complexity and globalization of biopharmaceutical research and development.
According to Dr. Albert Siu, vice president, learning and development, PAREXEL International, “The Academy’s location in Singapore provides students with access to a significant business center for the Asia/Pacific region, and supports regional growth in the clinical development field. These graduates will be empowered with the proper education to make a difference in the delivery of innovative new treatments to patients.”
“For biomedical sciences companies looking to succeed in the rapidly-emerging Asian biopharmaceutical industry, Singapore offers a vantage point in Asia from which they can develop the requisite international and multidisciplinary talent to support their growth. The establishment of the first PAREXEL Academy in Asia, in Singapore, underscores the importance of developing talent in a diverse Asian clinical environment,” said Mr. Kevin Lai, deputy director biomedical sciences, Singapore Economic Development Board.
Offering professional training and education since 2001, PAREXEL Academy, based in Berlin, Germany, provides postgraduate courses for clinical research associates, study nurses, and study coordinators. Training courses are also provided for investigators with special emphasis on conducting clinical trials in accordance with international conference on harmonization-good clinical practice (ICH-GCP) standards.